Posted by Michael Wonder on 21 Oct 2017
Agenda for 25 October TC meeting
20 October 2017 - HAS has posted the agenda for the next scheduled TC meeting.
The Transparency Commission will consider the reimbursement of:
- Nivolumab (Opdivo)
- C1 esterase inhibitor (human) (Cinryze)
